Author:
Van Ganse Eric, ,Texier Nathalie,Dima Alexandra L,Laforest Laurent,Ferrer Montserrat,Hernandez Gimena,Schuck Stéphane,Herbage Sandrine,Vial Delphine,de Bruin Marijn
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine
Reference15 articles.
1. Chowdhury BA, Dal Pan G . The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010; 362: 1169‑1171.
2. Cates CJ, Jaeschke R, Schmidt S, Ferrer M . Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2013; 3: CD006922.
3. Cates CJ, Jaeschke R, Schmidt S, Ferrer M . Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2013; 6: CD006924.
4. Strom BL . Pharmacoepidemiology. John Wiley & Sons Ltd, 2008, p 1–889.
5. Hernández G, Avila M, Pont À, Garin O, Alonso J, Laforest L et al. Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies. Respir Res 2014; 15: 83.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献